Drugs / gpASIT+TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02560948 | Dec 2015 → Aug 2016 | seasonal allergic rhinitis | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gpASIT+TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02560948 ↗ |
| Route | Subcutaneous | “a subcutaneous immunotherapy with gpASIT+™ in patients with grass pollen-induced allergic rhinoconjunctivitis” NCT02560948 ↗ |